Gemp stock after hours

Spread/Res. -6,3%, -40%, -24%. Spread/Supp. 57% 

CRY Has Reason To Smile, AKCA Braces For Busy Year, GEMP ... GEMP closed Monday's trading at $7.34, down 2.26%. In after-hours, the stock was down 23.71% to $5.60. InspireMD Inc. has reported 57% revenue growth in the second quarter of 2018, thanks iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR ... Jul 25, 2019 · The stock rose 4.62% to $7.48 in after-hours trading. Cara Prices 5.5M Common Stock Offering At $23/Share. Cara Therapeutics Inc Gemphire Therapeutics Inc (NASDAQ: GEMP) announced a … CVM CEL-SCI Corp. — Stock Price and Discussion | Stocktwits

View %COMPANY_NAME% GEMP investment & stock information. Get the latest %COMPANY_NAME% GEMP detailed stock quotes, stock data, Real-Time 

View the latest NRBO stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of NEUROBO PHARMACEUTICALS, INC. After Hours : 14.01-1.89-11.89%. after Trump The Daily Biotech Pulse: Syndax Lung Cancer Trial ... Sep 25, 2018 · The stock slumped 17.01 percent to $6 in after-hours trading. GEMP) said its board has The stock fell 1.91 percent to $100 in after-hours trading. On The Fly - On The Fly: After Hours Movers AMRS;QHC;CATB ... BioXcel soars after SunTrust more than sextuples price target to $150. Shares of BioXcel Therapeutics are soaring after SunTrust Robinson Humphrey analyst Robyn Karnauskas more than sextupled her price target on the shares to $150 from $24. The stock in premarket trading is up 74%, or $17.60, to $41.45. Gemphire Therapeutics Announces Expected Closing Date of ...

In the months prior, the company saw its shares $GEMP go up in smoke after the to Beijing SL Pharmaceutical for the Chinese market for $2.5 million upfront, 

Today's After-Hours Movers. Gemphire Therapeutics Inc. (NASDAQ: GEMP) 119.5% HIGHER; announced that it achieved the primary endpoint, reduction of TGs by gemcabene, in its Phase 2b INDIGO-1 trial GEMP Stock Quote - NeuroBo Pharmaceuticals, Inc. Stock ... GEMP stock quote, chart and news. Get NeuroBo Pharmaceuticals, Inc.'s stock price today. Gemphire to combine with NeuroBo in reverse merger ... Jul 24, 2019 · Gemphire Therapeutics (NASDAQ:GEMP) and privately held NeuroBo Pharmaceuticals have agreed to merge. The combined company will do business as NeuroBo Pharmaceuticals, Inc. and will trade under the tic GEMP Stock Price, Forecast & News (Gemphire Therapeutics)

Nov 08, 2018 · Many General Electric (GE) retirees depend on the company for their pension and the stock for their portfolio. This works great when the company is healthy and the stock …

BioXcel soars after SunTrust more than sextuples price target to $150. Shares of BioXcel Therapeutics are soaring after SunTrust Robinson Humphrey analyst Robyn Karnauskas more than sextupled her price target on the shares to $150 from $24. The stock in premarket trading is up 74%, or $17.60, to $41.45. Gemphire Therapeutics Announces Expected Closing Date of ...

GEMP — Stock Price and Discussion | Stocktwits

Stock analysis for NeuroBo Pharmaceuticals Inc (GEMP) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Gemphire Therapeutics News | Markets Insider Gemphire Therapeutics News: This is the News-site for the company Gemphire Therapeutics on Markets Insider CRY Has Reason To Smile, AKCA Braces For Busy Year, GEMP Down After-hours NASDAQ, GEMP End of Day and Historical Stock Data ... Download Historical Stock Quotes for Gemphire Therapeutics Inc [NASDAQ,GEMP] in a range of formats. The worlds #1 website for end of day & historical stock data wide range of exchanges, data formats, tools and services Download stock quote history quickly and easily in a variety of formats to suit your needs. NRBO - Stock quote for NEUROBO PHARMACEUTICALS, INC - …

Gemphire Therapeutics Announces Expected Closing Date of ... Dec 30, 2019 · ANN ARBOR, Mich., Dec. 30, 2019 (GLOBE NEWSWIRE) -- The pending merger between Gemphire Therapeutics Inc. (NASDAQ:GEMP) and NeuroBo Pharmaceuticals, Inc. is currently expected to close after market hours today, Monday, December 30, 2019, subject to satisfaction or waiver of all closing conditions. As previously announced, Gemphire's stockholders voted to approve the proposals …